bioAffinity Technologies, Inc.
Data quality: 100%
$3.32
▼
$0.60
(-15.31%)
Mkt Cap: 14.94 M
Price
$3.32
Mkt Cap
14.94 M
Day Range
$3.01 — $3.85
52-Week Range
$0.69 — $18.30
Volume
925,835
Open $3.78
50D / 200D Avg
$1.85
79.65% above
50D / 200D Avg
$4.06
18.20% below
Quick Summary
Key Takeaways
Debt/Equity of 0.01 — conservative balance sheet
Negative free cash flow of -9.39 M
Capital efficient — spends only 0.98% of revenue on capex
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)-34.18%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-440.72%
Below sector avg (-15.95%)
ROIC-142.32%
Net Margin-241.96%
Op. Margin-171.58%
Safety
Debt / Equity
0.01
Below sector avg (0.39)
Current Ratio3.65
Interest Coverage-238.27
Valuation
PE (TTM)
-1.00
Above sector avg (-1.17)
P/B Ratio1.68
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Services sector median (502 peers)
Peer Comparison
vs Services sector median (502 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -1.0 | -1.2 |
| P/B | 1.7 | 1.4 |
| ROE % | -440.7 | -16.0 |
| Net Margin % | -242.0 | -19.4 |
| Rev Growth 5Y % | — | 4.0 |
| D/E | 0.0 | 0.4 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -34.18% | Revenue Growth (3Y) | -11.68% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 6.16 M | Net Income (TTM) | -14.91 M |
| ROE | -440.72% | ROA | -182.97% |
| Gross Margin | N/A | Operating Margin | -171.58% |
| Net Margin | -241.96% | Free Cash Flow (TTM) | -9.39 M |
| ROIC | -142.32% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.01 | Current Ratio | 3.65 |
| Interest Coverage | -238.27 | Asset Turnover | 0.76 |
| Working Capital | 6.25 M | Tangible Book Value | 6.77 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -1.00 | Forward P/E | N/A |
| P/B Ratio | 1.68 | P/S Ratio | 2.42 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -62.86% | ||
| Market Cap | 14.94 M | Enterprise Value | 7.39 M |
| Per Share | |||
| EPS (Diluted TTM) | -8.66 | Revenue / Share | 1.37 |
| FCF / Share | -2.09 | OCF / Share | -2.07 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 0.98% | FCF Conversion | 62.97% |
| SBC-Adj. FCF | -10.18 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 6.16 M | 9.36 M | 7.90 M | 4,803.0 |
| Net Income | -14.91 M | -9.04 M | -7.94 M | -8.15 M |
| EPS (Diluted) | -8.66 | -0.75 | -0.91 | — |
| Gross Profit | — | — | — | 4,336.0 |
| Operating Income | -10.57 M | -8.95 M | -7.97 M | -4.01 M |
| EBITDA | — | — | — | — |
| R&D Expenses | 1.38 M | 1.46 M | 1.47 M | 1.14 M |
| SG&A Expenses | 9.91 M | 9.94 M | 6.79 M | 2.73 M |
| D&A | 504,836.0 | 605,637.0 | 249,592.0 | 10,182.0 |
| Interest Expense | 44,372.0 | 92,475.0 | 37,125.0 | 2.53 M |
| Income Tax | 44,042.0 | 11,650.0 | 20,993.0 | 2,459.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Total Assets | 10.96 M | 6.51 M | 8.22 M | 12.18 M |
| Total Liabilities | 3.68 M | 3.91 M | 3.37 M | 1.14 M |
| Shareholders' Equity | 7.28 M | 2.60 M | 4.86 M | 11.04 M |
| Total Debt | 127,500.0 | — | — | — |
| Cash & Equivalents | 6.45 M | 1.11 M | 2.82 M | 11.41 M |
| Current Assets | 7.57 M | 2.70 M | 3.97 M | 11.96 M |
| Current Liabilities | 2.91 M | 3.10 M | 2.25 M | 1.14 M |
{"event":"ticker_viewed","properties":{"ticker":"BIAF","listing_kind":"stock","pathname":"/stocks/biaf","exchange":"Nasdaq","country":"US"}}